Patents by Inventor Svetlana Doronina

Svetlana Doronina has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050113308
    Abstract: Pentapeptide compounds are disclosed. The compounds have biological activity, e.g., cytotoxicity. Prodrugs having targeting groups and pentapeptide moieities, as well as precursors thereof are also disclosed. For example, precursors having a reactive linker that can serve as a reaction site for joining to a targeting agent, e.g., an antibody, as disclosed.
    Type: Application
    Filed: November 1, 2004
    Publication date: May 26, 2005
    Inventors: Peter Senter, Brian Toki, Svetlana Doronina
  • Patent number: 6884869
    Abstract: Pentapeptide compounds are disclosed. The compounds have biological activity, e.g., cytotoxicity. Prodrugs having targeting groups and pentapeptide moieities, as well as precursors thereof are also disclosed. For example, precursors having a reactive linker that can serve as a reaction site for joining to a targeting agent, e.g., an antibody, as disclosed.
    Type: Grant
    Filed: November 1, 2001
    Date of Patent: April 26, 2005
    Assignee: Seattle Genetics, Inc.
    Inventors: Peter D. Senter, Brian E. Toki, Svetlana Doronina
  • Publication number: 20050009751
    Abstract: Pentapeptide compounds are disclosed. The compounds have biological activity, e.g., cytotoxicity. Prodrugs having targeting groups and pentapeptide moieities, as well as precursors thereof are also disclosed. For example, precursors having a reactive linker that can serve as a reaction site for joining to a targeting agent, e.g., an antibody, as disclosed.
    Type: Application
    Filed: November 1, 2001
    Publication date: January 13, 2005
    Inventors: Peter Senter, Brian Toki, Svetlana Doronina
  • Publication number: 20040157782
    Abstract: Pentapeptide compounds are disclosed. The compounds have biological activity, e.g., cytotoxicity. Prodrugs having targeting groups and pentapeptide moieities, as well as precursors thereof are also disclosed. For example, precursors having a reactive linker that can serve as a reaction site for joining to a targeting agent, e.g., an antibody, as disclosed.
    Type: Application
    Filed: March 29, 2004
    Publication date: August 12, 2004
    Inventors: Svetlana Doronina, Peter D. Senter, Brian E. Toki
  • Publication number: 20030083263
    Abstract: Pentapeptide compounds are disclosed. The compounds have biological activity, e.g., cytotoxicity, and/or include a reactive linker that can serve as a reaction site for joining to a targeting agent, e.g., an antibody.
    Type: Application
    Filed: April 30, 2001
    Publication date: May 1, 2003
    Inventors: Svetlana Doronina, Brian Toki, Peter Senter